Development: Head of Regulatory Affairs

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways, with particular emphasis on RAS and mTOR signaling pathways. As a new member of the Revolution Medicines team, you will join other outstanding colleagues who are helping lead our efforts in the discovery and development of new medicines for unmet needs in cancer.


This is a unique opportunity for an experienced, senior level Regulatory Affairs professional who has global clinical regulatory strategy expertise. As the Head of Regulatory Affairs, you will possess a deep understanding of global drug development regulation, guidelines, and initiatives and be accountable for the following:

  • Regulatory strategy, including timing and nature of global regulatory interactions.

  • Generation of regulatory documents that are required for regulatory interactions.

  • Keeping up to date in the relevant disease areas, including anticipating changes in standard of care as perceived by regulatory authorities and other key customers.

  • Maintaining an expert knowledge of the relevant regulatory landscape.

  • Maintaining a relationship with, and representing the company to, regulators and their agents, relevant external experts in the field, corporate partners, and other advisors.

  • Building a business plan for the regulatory function within Revolution Medicines.

  • With the Head Clinical Development, helping to ensure the success of the Research and Development Leadership Team and the success of the technical oversight committee for Revolution Medicines programs (Project Review Group).

  • For the right candidate, there is an opportunity to run a multi-disciplinary development team.

Required Skills
  • Bachelor’s degree or higher degree in a relevant discipline with hands-on experience of regulatory affairs with at least 7 years of experience within an industry setting; experience of clinical regulatory strategy in oncology would be a distinct advantage.

  • Demonstrable record of strong leadership and teamwork.

  • Thrives in a collaborative team setting and is driven by a desire to deploy innovative approaches and technologies in a high energy environment.

  • Excellent written and verbal communication skills.

  • Ability to act as an excellent ambassador for Revolution Medicines in interactions with key opinion leaders, scientific advisors, corporate partners and, where necessary, investors.

  • Demonstrated ability to multi-task, prioritize options, anticipate challenges, and execute on goals as a member of an interdisciplinary team is extremely important.